$NHI

NATIONAL HEALTH INVESTORS INC (NHI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

NATIONAL HEALTH INVESTORS INC (NHI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 27, 2026, National Health Investors, Inc. (the “Company”) entered into a Change in Control Severance Agreement (

Original reporting
Published Aug 27, 2026, 8:08 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 27, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$NHI
Neutral
medium confidence
Mentioned
$NHI
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NHINeutralLow
01

Why it matters

The filing adds a new compensation liability and may affect future earnings estimates.

02

Market read

Primary disclosure of a severance agreement; modest impact on valuation and compensation outlook.

03

What to watch

The agreement includes tax‑optimization provisions that could mitigate cash impact.

Relevance 6/10Novelty 5/10Timing: filed Aug 27 2026

Background

National Health Investors filed an 8‑K reporting a Change in Control severance agreement with an executive, outlining cash and benefit terms.

Company-level read

Ticker impact

$NHINeutralMedium confidence
Context

SEC Form 8‑K discloses a Change in Control severance agreement for executive Christian Maingot, detailing lump‑sum cash payments and accelerated vesting.

Expected impact

Potential modest downside pressure as investors assess additional severance liability.

Evidence & confidence

Severance terms are material for compensation risk but unlikely to move the stock sharply.

Market effects

May signal tighter executive compensation controls in the health‑investment sector.

Limited to U.S. markets where NHI trades.

Low

Counterpoint

Investors could view the agreement as a sign of upcoming change‑of‑control activity, potentially bullish.

Key entities

  • National Health Investors Inc.

    Issuer of the 8‑K filing.

  • Christian Maingot

    Executive receiving the severance agreement.

Related articles

$NHIHighAI 8/10

NHI (NHI) Q2 2026 Earnings Call Transcript

NHI reported Q2 2026 earnings with net income per share up 45.6% to $1.15, driven by real estate sales. NAREIT FFO per share remained flat at $1.19, while normalized FFO per share decreased 2.5% due to transition costs. The company completed a $560M portfolio sale, increasing liquidity and reducing leverage. NHI plans to expand its senior housing operating portfolio (SHOP) to 40-50% of its total portfolio within three years, with $127.3M in new investments under signed letters of intent. The qua

$NHIMed

National Health Investors, Inc. Q2 2026 Earnings Call Summary

National Health Investors (NHI) reported Q2 2026 updates, including completion of the NHC portfolio sale on July 1 and plans to redeploy $334 million via Section 1031 exchanges. It said SHOP investment rose 137% to about $850 million and targets 40% to 50% of total NOI over three years. Management guided for 8% to 9% same-store SHOP NOI growth in 2H.

$NHIMed

NHI accelerates senior living pivot with completion of SNF-focused portfolio sale

National Health Investors (NHI) said it completed the sale of its National HealthCare Corp. portfolio of 32 skilled nursing facilities and three independent living communities, as part of a shift toward private-pay senior housing. NHI reported $273.2M YTD investments, including $212.0M in SHOP, and aims for SHOP to reach 40%-50% of its portfolio. It also hired a new COO and reported SHOP NOI up 188.5% YoY.

$NHIMed

National Health Investors Q2 Earnings Call Highlights

National Health Investors (NYSE:NHI) reported Q2 results with normalized FFO per share down 2.5% to $1.19 and funds available for distribution up 5.8% to $61.6 million. The board raised its quarterly dividend to $0.94 per share. NHI completed a $560 million sale of its NHC portfolio, expecting about a $541.6 million gain in Q3 and using proceeds for replacement properties and Section 1031 reinvestment.

$NHIMed

National Health Investors: Q2 Earnings Snapshot

National Health Investors Inc. (NHI) reported Q2 funds from operations of $57.8 million, or $1.19 per share, and net income of $55.6 million, or $1.15 per share, with revenue of $121.3 million. The REIT expects full-year funds from operations of $4.74 to $4.79 per share, according to the company.